Delivery Order SPE2DB22D3016-SPE2DB25FBJB8
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,607.87 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This competitive award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $22,277.57 to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This competitive award, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,156.22 to supply Activase 50 mg vials, a thrombolytic medication used in emergency medical settings. The delivery order, issued on June 2, 2025, represents a firm fixed price contract with an ultimate completion date of June 3, 2025, and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,019.04 to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This firm fixed price contract, awarded on June 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a $11.87K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in emergency medical treatment. This competitively awarded, firm fixed-price delivery order was executed on May 30, 2025, with a completion deadline of June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order represents a task...
- The Defense Logistics Agency awarded a $35,956.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a competitively awarded, non-set-aside order fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a $35.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Activase 100 mg vials, with completion scheduled for September 10, 2025. The contract is unclassified as a set-aside and represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.75 to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials. This firm fixed price contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procurement with no set-aside designation. Performance will take place at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials under a firm fixed-price contract valued at approximately $26,000. The order was competitively awarded without set-aside designation and is scheduled for completion by June 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location at the same address. This...